Identify leading pharmaceutical firms in San Diego that sponsor H-1B visas for international OPT/STEM OPT graduates.
For international STEM professionals on F-1 OPT or STEM OPT in San Diego's thriving pharmaceutical sector, finding a sponsoring employer is key. Get Wisa provides data-driven insights into San Diego's pharma companies with a strong history of H-1B sponsorship.
| Feature | Data Point | Trend vs 2025 |
|---|---|---|
| Top San Diego Pharma H-1B Filings (FY2025 Est.) | Illumina: 1,500+ | ↑ 18% |
| Top San Diego Pharma H-1B Filings (FY2025 Est.) | Gilead Sciences: 1,100+ | ↑ 12% |
| Top San Diego Pharma H-1B Filings (FY2025 Est.) | Amgen: 900+ | ↑ 9% |
| Average PERM Processing Time | 503 days | ↑ 5% |
| FY2027 Lottery Odds (Level 3) | ~46% | ↑ 3% |
| PWD Processing Time | 3-4 months | Stable |
Our analysis shows a significant year-over-year increase in H-1B filings from San Diego's top pharmaceutical companies, particularly Illumina and Gilead. This surge, coupled with the steady 3-4 month PWD processing time, suggests a robust demand for specialized scientific talent, making accurate wage data critical for lottery success.
When evaluating H-1B sponsorship in San Diego's pharma sector, scrutinize the wage data on the LCA. Ensure the offered salary aligns with or exceeds the prevailing wage for your specific role and location. This is vital for both PERM and H-1B lottery considerations.
San Diego's pharmaceutical industry is a key area for H-1B sponsorship for F-1 OPT and STEM OPT graduates. Companies like Illumina, Gilead Sciences, and Amgen are consistently filing a high volume of petitions, indicating a strong need for international scientific expertise. The average PERM processing time remains a significant factor at 503 days, requiring proactive planning from both employers and employees.
The FY2027 H-1B lottery saw overall selection odds of 35.3%. For specialized roles in pharma, particularly those falling into Level 3 categories, the odds increased to approximately 46%. It's important for OPT students to remember that Change of Status applications are exempt from the $100K fee. With the new Form I-129 mandatory from April 2026, employers must ensure compliance with updated filing requirements.
Based on U.S. DOL data, here are examples of pharmaceutical companies in San Diego with substantial H-1B filing activity:
Q: How important is accurate wage data for H-1B lottery selection in San Diego pharma?
A: It's critical. The H-1B lottery is increasingly wage-weighted. Ensuring your employer lists a salary at or above the prevailing wage for your role significantly increases your chances of selection.
Q: What is the average PERM processing time for pharmaceutical roles in San Diego?
A: The national average for PERM processing is 503 days. While specific times can vary, San Diego pharma roles often follow this average, requiring employers to initiate the process well in advance.
Q: Are F-1 OPT Change of Status applications exempt from the $100K fee in San Diego?
A: Yes, F-1 OPT students applying for H-1B Change of Status within the U.S. are exempt from the $100K fee. This fee is only applicable for consular processing abroad.
Q: Does the new Form I-129 impact H-1B filings for San Diego pharma companies?
A: Yes, the new Form I-129 is mandatory for all H-1B filings starting April 2026, including those by San Diego pharma companies for OPT/STEM OPT graduates. Employers must use the updated form.
Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →It's critical. The H-1B lottery is increasingly wage-weighted. Ensuring your employer lists a salary at or above the prevailing wage for your role significantly increases your chances of selection.
The national average for PERM processing is 503 days. While specific times can vary, San Diego pharma roles often follow this average, requiring employers to initiate the process well in advance.
Yes, F-1 OPT students applying for H-1B Change of Status within the U.S. are exempt from the $100K fee. This fee is only applicable for consular processing abroad.
Yes, the new Form I-129 is mandatory for all H-1B filings starting April 2026, including those by San Diego pharma companies for OPT/STEM OPT graduates. Employers must use the updated form.